The EMERGE Project: Feasibility of Assessing Economic and Sexual Risk Behaviors Using Text Messages in Young Adults
10 april 2019 uppdaterad av: Johns Hopkins Bloomberg School of Public Health
The Engaging Microenterprise for Resource Generation and Health Empowerment (EMERGE) Project: Feasibility of Assessing Economic and Sexual Risk Behaviors Using Text Messages in Homeless Young Adults
As part of the development of the Engaging Microenterprise for Resource Generation and Health Empowerment (EMERGE) Project, the study team will conduct a single-group study to examine the feasibility of assessing economic and sexual risk behaviors using text messages.
The team will enroll approximately 20 young adults, aged 18 to 24, who are African-American, homeless, out-of-school, and un/under-employed.
Participants will complete a text-messaged survey each week for 5 weeks.
The study team will collect information about the number of participants who respond to the weekly survey, the number of questions to which they respond in each survey, and the number of hours from sending a survey to participants to receiving their response.
As an exploratory aim, participants will also receive 3 informational text messages each week for 5 weeks on HIV prevention and economic empowerment.
The study team will obtain qualitative feedback from participants regarding text messages they most and least liked.
The survey is not designed to evaluate the effectiveness of the text message intervention.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Detaljerad beskrivning
As part of the development of the Engaging Microenterprise for Resource Generation and Health Empowerment (EMERGE) Project, the study team will conduct a single-group study to examine the feasibility of assessing economic and sexual risk behaviors using text messages.
The study team will enroll approximately 20 young adults, aged 18 to 24, who are African-American, homeless, out-of-school, and un/under-employed.
Participants will complete a text-messaged survey each week for 5 weeks.
The study team will collect information about the number of participants who respond to the weekly survey, the number of questions to which they respond in each survey, and the number of hours from sending a survey to participants to receiving their response.
As an exploratory aim, participants will also receive 3 informational text messages each week for 5 weeks on HIV prevention and economic empowerment.
The study team will obtain qualitative feedback from participants regarding text messages they most and least liked.
The survey is not designed to evaluate the effectiveness of the text message intervention.
The single-group study is anticipated to start in August 2017.
Studietyp
Interventionell
Inskrivning (Faktisk)
17
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Maryland
-
Baltimore, Maryland, Förenta staterna, 21205
- Johns Hopkins Bloomberg School of Public Health
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år till 24 år (Vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- Individuals will be included in the study if, at the time of enrollment, they are:
- African American
- Aged 18-24
- Living in Baltimore City
- Experiencing homelessness in the past 12 months
- Employed fewer than 10 hours per week
- Not enrolled in school
- Ownership of a mobile phone with text-messaging capacity
- Reporting at least one episode of unprotected sex in prior 6 months or one other personal or sexual partner HIV risk factor within prior 6 months (STI diagnosis, sex while high or drunk, sex exchange, illicit drug use, alcohol dependence).
Exclusion Criteria:
- Aged 17 or younger.
- Older than 24 years
- Unwilling to provide consent for study participation
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Övrig
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Survey and informational text messages
Text-message survey and informational text messages
|
Participants will complete a text-messaged survey each week for 5 weeks assessing economic and sexual risk behaviors.
Participants will also receive 3 informational text messages each week for 5 weeks on HIV prevention and economic empowerment.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Number of Participants Who Respond to the Survey in Week 1
Tidsram: Week 1
|
Number of enrolled participants who respond to the survey in Week 1. Measure type 'number' was used for small sample size and as described in the original registration protocol.
|
Week 1
|
|
Mean Number of Questions to Which Participant Respond in Each Survey in Week 1
Tidsram: Week 1
|
Mean number of questions to which enrolled participant respond in each survey in Week 1.
|
Week 1
|
|
Mean Number of Hours From Sending a Survey to Participants to Receiving Their Response in Week 1
Tidsram: Week 1
|
Mean number of hours from sending a survey to enrolled participants to receiving their response in Week 1.
|
Week 1
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Samarbetspartners
Utredare
- Huvudutredare: Larissa Jennings, PhD MHS, Johns Hopkins Bloomberg School of Public Health
Publikationer och användbara länkar
Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
7 juli 2017
Primärt slutförande (Faktisk)
19 september 2017
Avslutad studie (Faktisk)
19 september 2017
Studieregistreringsdatum
Först inskickad
25 juli 2017
Först inskickad som uppfyllde QC-kriterierna
31 juli 2017
Första postat (Faktisk)
3 augusti 2017
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
12 april 2019
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
10 april 2019
Senast verifierad
1 april 2019
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- IRB0007563
- K01MH107310 (U.S.S. NIH-anslag/kontrakt)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Ja
IPD-planbeskrivning
All de-identified IPD that underlie results in a publication will be shared.
Tidsram för IPD-delning
De-identified individual patient data (IPD) that under results in a publication will become available 12 months after publication and will be available for 24 months.
Kriterier för IPD Sharing Access
Sponsor approval for data sharing will be sought.
Only bona fide research groups are eligible to access data as evidenced via curriculum vitae (CV) and the involvement of a qualified statistician or qualitative research scientist.
Data access requests should be made via email application to the principal investigator detailing the specific requirements and the proposed research and publication plan.
Data access requests will be reviewed against specific criteria by the data custodians.
Decisions about requests will be made promptly and no more than 3 months after receipt of request.
IPD-delning som stöder informationstyp
- Studieprotokoll
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
produkt tillverkad i och exporterad från U.S.A.
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .